Covered recipient · General Payments record
ROSLYN POSNER EINBINDER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2019–2025
$2,676.08
- Reported across 168 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.92 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $154.08 | 6 |
| EMD Serono, Inc. | $74.52 | 4 |
| Axsome Therapeutics, Inc. | $70.06 | 3 |
| PFIZER INC. | $54.48 | 3 |
| Lundbeck LLC | $30.78 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.94 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807159 | CMS |
| ABBVIE INC. | $19.50 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807161 | CMS |
| ABBVIE INC. | $27.90 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807163 | CMS |
| ABBVIE INC. | $28.04 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807165 | CMS |
| ABBVIE INC. | $31.94 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807167 | CMS |
| ABBVIE INC. | $29.76 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201807169 | CMS |
| Axsome Therapeutics, Inc. | $18.67 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235442284 | CMS |
| Axsome Therapeutics, Inc. | $25.13 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235494995 | CMS |
| Axsome Therapeutics, Inc. | $26.26 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235569004 | CMS |
| EMD Serono, Inc. | $13.65 | 03/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236915156 | CMS |
| EMD Serono, Inc. | $13.51 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236906977 | CMS |
| EMD Serono, Inc. | $25.53 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236908275 | CMS |
| EMD Serono, Inc. | $21.83 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1236891603 | CMS |
| Lundbeck LLC | $13.72 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251792275 | CMS |
| Lundbeck LLC | $17.06 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251792277 | CMS |
| PFIZER INC. | $13.65 | 01/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231546855 | CMS |
| PFIZER INC. | $14.67 | 04/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230061499 | CMS |
| PFIZER INC. | $26.16 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229412899 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.